For citations:
Nechushkina V.M., Khokhlova S.V., Nosov D.A., Ulrikh E.A., Kolomiets L.A., Rumyantsev A.A., Raskin G.A. Lenvatinib and pembrolizumab role in the first line in endometrial cancer treatment Consensus review and expert opinion. Tumors of female reproductive system. 2025;21(2):127-134. (In Russ.) https://doi.org/10.17650/1994-4098-2025-21-2-127-134